Letter by Imprialos et al Regarding Article, “Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.